cetylpyridinium chloride anhydrous has been researched along with Acromegaly in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chin, SO; Chung, CH; Chung, YS; Kim, BJ; Kim, HY; Kim, IJ; Kim, JG; Kim, MS; Kim, SW; Kim, SY; Lee, EJ; Lee, KY | 1 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and Acromegaly
Article | Year |
---|---|
Change in quality of life in patients with acromegaly after treatment with octreotide LAR: first application of AcroQoL in Korea.
Topics: Acromegaly; Activities of Daily Living; Adult; Aged; Antineoplastic Agents, Hormonal; Female; Health; Health Status; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Octreotide; Outcome Assessment, Health Care; Physical Appearance, Body; Prospective Studies; Quality of Life; Republic of Korea; Surveys and Questionnaires; Young Adult | 2015 |